Panel Discussion: Aligning Preclinical Model Selection with Regulatory Expectations to Improve Translation & Approval Confidence

• Evaluating mouse and non-human primate model translatability to improve clinical predictability
• Comparing model suitability across therapy types to highlight strategic differences that reduce regulatory risk
• Discussing gaps between required regulatory model data and biopharma efficacy needs to align development strategies with translational approval

Speakers:

Aaron Edwards

Co-Founder & Chief Executive Officer

KiraGen Bio

Matthias bozza

Head of RnD

CPTx